Stocks-SNY-Sanofi-ADR

SNY Sanofi-ADR

46.34 -0.68 (-1.45%)
Markt geslotenVertraagde koersen door NASDAQ, in USD
Handelen

Sanofi-ADR prijs

0% Afgelopen week
Marktkapitalisatie
116.21B
Dagbereik
46.27
-
46.69
52W Bereik
42.56
-
57.72
Volume (3M)
2.03M
Prijs-Winstverhouding
12.94
Inkomsten
45.33B

Sanofi-ADR Laatste nieuws

Bekijk alle
Vastgezet bericht
Obesity and Diabetes Drugs
Roche joins race for obesity drugs with $2.7 billion Carmot deal 👉 $ROG.ZU (Roche Holding Ltd) agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs $NVO (Novo-Nordisk... Meer weergeven Vertalen
Like ReactieDelen
null
.
Top Discussies
Matteo Boscolo
Bewerkt
Dear eTorians, Dear followers, 🙌🏼🙌🏼 I am so pleased to announce I have been admitted to the Popular Investor program 🎉🥂🥳 🔷Starting from Cadet ranking, aiming to climb the levels as much as i will deserve! How am I going to achieve my goals? 1️⃣ Being consistent with my investment strategy... Meer weergeven Vertalen
Like ReactieDelen
3 reacties
null
.
Nikolay Toskov
𝐒𝐚𝐧𝐨𝐟𝐢 (𝐒𝐍𝐘): 𝐀 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐓𝐢𝐭𝐚𝐧 𝑨 𝑹𝒐𝒃𝒖𝒔𝒕 𝑷𝒐𝒓𝒕𝒇𝒐𝒍𝒊𝒐 𝒂𝒏𝒅 𝒂 𝑷𝒓𝒐𝒎𝒊𝒔𝒊𝒏𝒈 𝑭𝒖𝒕𝒖𝒓𝒆 $SNY (Sanofi-ADR), a French multinational corporation, is a titan in the pharmaceutical industry with a robust product portfolio and a promising pipeline. This... Meer weergeven Vertalen
Like ReactieDelen
Toon meer opmerkingen2 van 3
null
.
Geffry Opuhara Salmon
**THIS WEEKS WATCHLIST** **Bullish Setups** $SNY (Sanofi-ADR) - Decent uptrend from the start of the month off of $44 level. Good pharma stock we have traded prior. $ENB (Enbridge Inc) - Nice uptrend since October from $31 lows. Good relative strength even as oil/energy prices have dropped. **Bearish... Meer weergeven Vertalen
Like ReactieDelen
null
.
Matteo Boscolo
Bewerkt
Like ReactieDelen
null
.
Matteo Boscolo
**** MONTHLY REPORT **** 🟢 November 2023 —> + 9,83% 🟢🚀 YTD performance —> + 78,04% ✅ Risk score lowered to 4 During this month I was able to recover part of the loss of september and october thanks to the rally of $SPX500 and $NSDQ100. Also able to add new funds, to balance the potfoflio... Meer weergeven

Komende evenementen

1
FEB
RAPPORTEN
Sanofi-ADR Q4 2023 inkomstenrapport verwacht te worden uitgebracht voor het openen van de markt

Mensen kochten ook